Evaluation and Clinical Management of Alzheimer's Disease - Blake Finn - Libros - Foster Academics - 9781632427885 - 24 de junio de 2019
En caso de que portada y título no coincidan, el título será el correcto

Evaluation and Clinical Management of Alzheimer's Disease

Precio
$ 129,49
sin IVA

Pedido desde almacén remoto

Entrega prevista 22 de jun. - 9 de jul.
Añadir a tu lista de deseos de iMusic

AlzheimerÂ’s disease is a chronic neurodegenerative disease. Usually it begins slowly, but worsens with the passage of time. In most of the cases, it is the cause of dementia, i.e., a decrease in the ability to think and remember. Symptoms of AlzheimerÂ’s disease include short-term memory loss, mood swings, disorientation, problems with language and inability to manage self. The causes of AlzheimerÂ’s disease are found to be genetic in most of the cases. Cognitive testing with medical imaging and blood tests is often used for the purpose of diagnosis. There is no known cure for AlzheimerÂ’s disease. It is managed with pharmaceutical and psychosocial therapies. Some medications used to treat the cognitive issues linked with the disease are acetylhocholinesterase inhibitors and mematine. Psychological interventions encompass emotion-, behavior-, cognition-, and stimulation- oriented approaches. These are used along with pharmaceutical treatment. The topics included in this book on AlzheimerÂ’s disease are of utmost significance and bound to provide incredible insights to readers. It aims to shed light on some of the unexplored aspects of evaluation and management of this disease. This book will serve as a reference to a broad spectrum of readers.

Medios de comunicación Libros     Hardcover Book   (Libro con lomo y cubierta duros)
Publicado 24 de junio de 2019
ISBN13 9781632427885
Editores Foster Academics
Páginas 222
Dimensiones 203 × 276 × 14 mm   ·   752 g
Lengua Inglés  

Mas por Blake Finn

Mostrar todo

Mere med samme udgiver